| Seq1_DS |
Strain was isolated in Russia belonging to the AI
family (according to RFLP genotyping) and it is sensitive to all
common drugs used in the treatment of tuberculosis. |
| Seq2_DS |
Susceptible strain representing the largest portion
of tuberculosis isolates recovered during an epidemic in the Western
Cape of South Africa. |
| Seq3_DS |
Susceptible strain belonging to the Beijing family,
sequenced for comparative genomic studies. |
| Seq4_DR |
Resistant strain isolated in 2004, referring to a
patient with secondary pulmonary tuberculosis, sequenced for
comparative genomic studies. |
| Seq5_DR |
Drug-resistant strain, having an accelerated rate of
transmission between humans under agglomeration conditions. |
| Seq6_MDR |
Strain from a single patient in KwaZulu-Natal, South
Africa. |
| Seq7_XDR |
Strain from a single patient in KwaZulu-Natal, South
Africa. |
| Seq8_DS |
Susceptible strain used for comparative genomic
studies. |
| Seq9_DS |
Susceptible strain derived from the original human
lung H37, isolated in 1934. It has been widely used all over the
world in biomedical research. Unlike some clinical isolates, it
retains total virulence in animals with tuberculosis and is
susceptible to drugs and receptive to genetic manipulation. |
| Seq10_DS |
A virulent susceptible strain derived from its
virulent parent strain H37 (isolated from a 19-year-old male patient
with chronic pulmonary tuberculosis, named Edward R. Baldwin in
1905). This strain was obtained through an aging and dissociation
process of an in vitro culture in 1935. |
